Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (801-810 of 1,482) with videos related to

Pageof 149
Sort By:
Gynecologic Oncology|February 27, 2021
Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivorsElizabeth Schrier, Niya Xiong, Embree Thompson, et al.
Cancer|March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemiaFadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
Medical Sciences (Basel, Switzerland)|November 24, 2025
Virtual Biomarkers and Simplified Metrics in the Modeling of Breast Cancer Neoadjuvant Therapy: A Proof-of-Concept Case Study Based on Diagnostic ImagingGraziella Marino, Maria Valeria De Bonis, Marisabel Mecca, et al.
Cancer|July 28, 2016
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomesTapan M Kadia, Preetesh Jain, Farhad Ravandi, et al.
American Journal of Hematology|September 28, 2016
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemiasBrittany Knick Ragon, Hagop Kantarjian, Elias Jabbour, et al.
Blood Cancer Journal|May 6, 2020
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemiaIman Abou Dalle, Ahmad Ghorab, Keyur Patel, et al.
Cancer|January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 MutationsDaniel A Pollyea, Courtney D DiNardo, Martha L Arellano, et al.
Journal of the American Heart Association|November 4, 2016
Phosphodiesterase Inhibitor-Based Vasodilation Improves Oxygen Delivery and Clinical Outcomes Following Stage 1 PalliationKimberly I Mills, Aditya K Kaza, Brian K Walsh, et al.
Epigenetics|August 29, 2020
Germline DNMT3A mutation in familial acute myeloid leukaemiaCourtney D DiNardo, Hannah C Beird, Marcos Estecio, et al.
Pageof 149

Showing results (801-810 of 1,482) with videos related to

Sort By:
Pageof 149
Gynecologic Oncology|February 27, 2021
Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivorsElizabeth Schrier, Niya Xiong, Embree Thompson, et al.
Cancer|March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemiaFadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
Medical Sciences (Basel, Switzerland)|November 24, 2025
Virtual Biomarkers and Simplified Metrics in the Modeling of Breast Cancer Neoadjuvant Therapy: A Proof-of-Concept Case Study Based on Diagnostic ImagingGraziella Marino, Maria Valeria De Bonis, Marisabel Mecca, et al.
Cancer|July 28, 2016
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomesTapan M Kadia, Preetesh Jain, Farhad Ravandi, et al.
American Journal of Hematology|September 28, 2016
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemiasBrittany Knick Ragon, Hagop Kantarjian, Elias Jabbour, et al.
Blood Cancer Journal|May 6, 2020
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemiaIman Abou Dalle, Ahmad Ghorab, Keyur Patel, et al.
Cancer|January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 MutationsDaniel A Pollyea, Courtney D DiNardo, Martha L Arellano, et al.
Journal of the American Heart Association|November 4, 2016
Phosphodiesterase Inhibitor-Based Vasodilation Improves Oxygen Delivery and Clinical Outcomes Following Stage 1 PalliationKimberly I Mills, Aditya K Kaza, Brian K Walsh, et al.
Epigenetics|August 29, 2020
Germline DNMT3A mutation in familial acute myeloid leukaemiaCourtney D DiNardo, Hannah C Beird, Marcos Estecio, et al.
Pageof 149